Advertisement
Screener

Q/C Technologies, Inc. (QCLS) Accounts Payable and Accrued Liabilities

1.2 / 5 stars · 16/66 Roast Me

Q/C Technologies, Inc. Accounts Payable and Accrued Liabilities

Q/C Technologies, Inc. (QCLS) had Accounts Payable and Accrued Liabilities of $3.17 thousand as of 2020-12-31, per its 10-K filed 2021-03-01.

Discontinued › Balance Sheet › Liabilities › Accounts Payable and Accrued Liabilities

us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent · last filed 2021-03-01

  • 2020-12-31: Accounts Payable and Accrued Liabilities $3.17K.
  • 2020-09-30: Accounts Payable and Accrued Liabilities $3.17K.
  • 2020-06-30: Accounts Payable and Accrued Liabilities $3.17K.
  • 2020-03-31: Accounts Payable and Accrued Liabilities $3.17K.
Period endAccounts Payable and Accrued Liabilities
2020-12-31$3.17K
10-K · filed 2021-03-01
2020-09-30$3.17K
10-Q · filed 2020-11-16
2020-06-30$3.17K
10-Q · filed 2020-08-14
2020-03-31$3.17K
10-Q · filed 2020-05-15
2019-12-31$471.00
10-Q · filed 2020-11-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
BIOMERICA INC (BMRA)United States$0.011B
VOLITIONRX LTD (VNRX)$0.003B-0.64
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92